| Silver nanoparticles as multi-functional drug delivery systems N Ivanova, V Gugleva, M Dobreva, I Pehlivanov, S Stefanov, V Andonova Nanomedicines, 71-92, 2018 | 119 | 2018 |
| Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system V Gugleva, S Titeva, S Rangelov, D Momekova International journal of pharmaceutics 567, 118431, 2019 | 74 | 2019 |
| Nanoarchitectonics of multifunctional niosomes for advanced drug delivery DB Momekova, VE Gugleva, PD Petrov ACS omega 6 (49), 33265-33273, 2021 | 43 | 2021 |
| Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery V Gugleva, S Titeva, N Ermenlieva, S Tsibranska, S Tcholakova, ... International Journal of Pharmaceutics 591, 120010, 2020 | 36 | 2020 |
| Dermal drug delivery of phytochemicals with phenolic structure via lipid-based nanotechnologies V Gugleva, N Ivanova, Y Sotirova, V Andonova Pharmaceuticals 14 (9), 837, 2021 | 31 | 2021 |
| Nanomedicines N Ivanova, V Gugleva, M Dobreva, I Pehlivanov, S Stefanov, V Andonova Intech Open, 2018 | 18 | 2018 |
| Formulation and evaluation of hybrid niosomal in situ gel for intravesical co-delivery of curcumin and gentamicin sulfate V Gugleva, V Michailova, R Mihaylova, G Momekov, MM Zaharieva, ... Pharmaceutics 14 (4), 747, 2022 | 17 | 2022 |
| Topical use of resveratrol: Technological aspects V Gugleva, S Zasheva, M Hristova, V Andonova Pharmacia 67 (2), 89-94, 2020 | 16 | 2020 |
| Recent progress of solid lipid nanoparticles and nanostructured lipid carriers as ocular drug delivery platforms V Gugleva, V Andonova Pharmaceuticals 16 (3), 474, 2023 | 13 | 2023 |
| Antioxidant Activity and Chemical Characteristics of Sambucus nigra L. Blossom from Different Regions in Bulgaria G Gentscheva, I Milkova-Tomova, K Nikolova, D Buhalova, V Andonova, ... Horticulturae 8 (4), 309, 2022 | 10 | 2022 |
| IntechOpen; London, UK: 2019 N Ivanova, V Gugleva, M Dobreva, I Pehlivanov, S Stefanov, ... Silver Nanoparticles as Multi-Functional Drug Delivery Systems.[Google Scholar], 0 | 9 | |
| Chemical characterization of selected algae and cyanobacteria from Bulgaria as sources of compounds with antioxidant activity G Gentscheva, I Milkova-Tomova, I Pehlivanov, V Gugleva, K Nikolova, ... Applied Sciences 12 (19), 9935, 2022 | 7 | 2022 |
| Doctors’ point of view on Pharmacy Compounding-Advantages and disadvantages A Todorova, V Gugleva, L Georgieva IAIM 3 (2), 45-50, 2016 | 7 | 2016 |
| Bigel Formulations of Nanoencapsulated St. John’s Wort Extract—An Approach for Enhanced Wound Healing Y Sotirova, V Gugleva, S Stoeva, I Kolev, R Nikolova, M Marudova, ... Gels 9 (5), 360, 2023 | 6 | 2023 |
| Water Quality Parameters N Ivanova, V Gugleva, M Dobreva, I Pehlivanov, S Stefanov, V Andonova Water Qual. Intech 1, 13, 2016 | 5 | 2016 |
| Drug delivery to the brain–lipid nanoparticles-based approach V Gugleva, V Andonova Pharmacia 70 (1), 113-120, 2023 | 4 | 2023 |
| Understanding Urban Mobility and Pedestrian Movement N Ivanova, V Gugleva, M Dobreva, I Pehlivanov, S Stefanov, V Andonova Smart Urban Development; IntechOpen: London, UK 1, 13, 2016 | 4 | 2016 |
| Aerosol vaccines–perspectives and therapeutic impact S Zasheva, V Gugleva, V Andonova Scripta Scientifica Pharmaceutica 7 (1), 18-25, 2020 | 2 | 2020 |
| Technological strategies for the preparation of lipid nanoparticles: an updated review. S Stefanov, V Gugleva, V Andonova Pharmacia (0428-0296) 70 (3), 2023 | 1 | 2023 |
| Topical use of resveratrol: technological aspects. Pharmacia 67 (2): 89–94 V Gugleva, S Zasheva, M Hristova, V Andonova | 1 | 2020 |
